RECENT PROGRESS AND CURRENT PROBLEMS IN TREATMENT OF INVASIVE FUNGAL INFECTIONS IN NEUTROPENIC PATIENTS
- 1 June 1996
- journal article
- review article
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 10 (2), 365-400
- https://doi.org/10.1016/s0891-5520(05)70303-2
Abstract
No abstract availableKeywords
This publication has 161 references indexed in Scilit:
- Cytokines in the treatment of fungal infectionsBiotherapy, 1994
- The potential role of granulocyte-macrophage colony stimulating factor in therapy of fungal infections: A commentaryEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- Lysis—centrifugation blood cultures in the detection of tissue-proven invasive candidiasis disseminated versus single-organ infectionDiagnostic Microbiology and Infectious Disease, 1993
- Systemically Administered Antifungal AgentsDrugs, 1992
- Safety and pharmacokinetics of fluconazole in children with neoplastic diseasesThe Journal of Pediatrics, 1992
- A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow TransplantationNew England Journal of Medicine, 1992
- Itraconazole treatment of phaeohyphomycosisJournal of the American Academy of Dermatology, 1990
- FluconazoleDrugs, 1990
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow TransplantationNew England Journal of Medicine, 1988
- Lethal Pulmonary Reactions Associated with the Combined Use of Amphotericin B and Leukocyte TransfusionsNew England Journal of Medicine, 1981